Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
FRTX was delisted on the 18th of December, 2023.
36 hedge funds and large institutions have $9.18M invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2016 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 5 reducing their positions, and 5 closing their positions.
160% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 5
0% more funds holding
Funds holding: 36 → 36 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
11% less call options, than puts
Call options by funds: $76K | Put options by funds: $85K
30% less capital invested
Capital invested by funds: $13.1M → $9.18M (-$3.93M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$260K |
| 2 |
CAM
ClariVest Asset Management
San Diego,
California
|
+$98.4K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$78.2K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$61.8K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$53K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$63K |
| 2 |
Bank of New York Mellon
New York
|
-$48K |
| 3 |
Wolverine Trading
Chicago,
Illinois
|
-$46K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$31.5K |
| 5 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
-$26.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Group One Trading
Chicago,
Illinois
| $12K | +$12.6K | +10 | +500% |
|
|
BA
27
BlackRock Advisors
Wilmington,
Delaware
| $9K | – | – | – |
|
28
UBS Group
Zurich,
Switzerland
| $6K | +$5.05K | +4 | +200% |
|
|
BIM
29
BlackRock Investment Management
Wilmington,
Delaware
| $5K | – | – | – |
|
30
Citigroup
New York
| $5K | – | – | – |
|
|
WEC
31
Winslow Evans & Crocker
Boston,
Massachusetts
| $4.8K | – | – | – |
|
|
AIM
32
Acrospire Investment Management
Chicago,
Illinois
| $1K | -$26.5K | -21 | -95% |
|
|
GC
33
Globeflex Capital
San Diego,
California
| $1K | +$1.26K | +1 | New |
|
34
Morgan Stanley
New York
| $1K | +$1.26K | +1 | +100% |
|
|
TRCT
35
Tower Research Capital (TRC)
New York
| $1K | +$1.26K | +1 | New |
|
|
36
Citadel Advisors
Miami,
Florida
| – | -$63K | -44 | Closed |
|
|
37
Bank of New York Mellon
New York
| – | -$48K | -34 | Closed |
|
|
38
Wolverine Trading
Chicago,
Illinois
| – | -$46K | -32 | Closed |
|
39
JP Morgan Chase
New York
| – | -$9K | -6 | Closed |
|
40
Simplex Trading
Chicago,
Illinois
| – | -$5.05K | -4 | Closed |
|
41
First Manhattan
New York
| – | -$1.26K | -1 | -50% |
|
FRTX Hedge Fund Activity: Q3 2016 in Review
36 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q3 2016, worth a combined $9.18M — down 30% from $13.1M a quarter earlier.
Fund positioning in FRTX was balanced in Q3 2016: 5 funds opened new positions, 5 closed out, 13 added to existing stakes and 5 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $260K. The largest seller was Citadel Advisors, exiting entirely with an estimated $63K sold.
- 36 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q3 2016, unchanged from Q2 2016.
- Funds reported $9.18M of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q3 2016, down 30% quarter-over-quarter.
- 5 funds opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q3 2016 and 5 closed out, a net change of 0 holders.
- The largest Fresh Tracks Therapeutics, Inc. Common Stock buyer in Q3 2016 was Renaissance Technologies, an estimated $260K added.
- The largest Fresh Tracks Therapeutics, Inc. Common Stock seller in Q3 2016 was Citadel Advisors, an estimated $63K sold.
Based on aggregated 13F filings for Q3 2016.